 Anlotibib AL3818 is a kind of innovative medicines approved by State Food and Drug AdministrationSFDA:2011L00661 which was researched by Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd.To compare the effects and safety of Anlotinib with placebo in patients with metastatic colorectal cancer refractory to standard chemotherapies. 